Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chronopharmacological study of intrathecal sufentanil and ropivacaine for combined spinal-epidural labor analgesia
ChiCTR2300067661Phase 4Not yet recruiting
- Sponsor
- Xuzhou Central Hospital
- Start
- Jan 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sufentanil and ropivacaine in labor pain (4 arms), sponsored by Xuzhou Central Hospital. Primary endpoint: Duration of analgesia. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
sufentanilropivacaine
03
Conditions
labor pain
Beyond the preview
Go deeper on ChiCTR2300067661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300067661.